Related content

Clinical efficacy and cost-effectiveness of HP-human FSH (Fostimon®) versus rFSH (Gonal-F®) in IVF-ICSI cycles: a meta-analysis

By Gerli Sandro  

Gynecological Endocrinology, Vol. 29, Iss. 6, 2013-06 ,pp. : 520-529

Informa Healthcare

Access to resources Recommend Favorite

Endocrinology. Recombinant human FSH versus highly purified urinary FSH: a randomized study in intrauterine insemination with husbands' spermatozoa

By Matorras R.   Recio V.   Corcóstegui B.  

Human Reproduction, Vol. 15, Iss. 6, 2000-06 ,pp. : 1231-1234

Oxford University Press

Access to resources Recommend Favorite

Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques.

By Bergh C   Howles C M   Borg K   Hamberger L   Josefsson B   Nilsson L   Wikland M  

Human Reproduction, Vol. 12, Iss. 10, 1997-10 ,pp. : 2133-2139

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK

By Daya S.  

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2563-2569

Oxford University Press

Access to resources Recommend Favorite

Efficacy of recombinant versus human derived follicle stimulating hormone on the oocyte and embryo quality in IVF-ICSI cycles: Randomised, controlled, multi-centre trial

By Abate Antonino   Nazzaro Alfredo   Salerno Annalisa   Marzano Francesca   Pavone Cossut Maria   Perino Maria  

Gynecological Endocrinology, Vol. 25, Iss. 8, 2009-08 ,pp. : 479-484

Informa Healthcare

Access to resources Recommend Favorite